Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study

Exclusion Criteria

• •1. Subject has Dysphagia, odynophagia, known swallowing disorder or history of Zencker's diverticulum
• •2. Subject is known or is suspected to suffer from bowel obstruction or bowel perforation at the time of presentation
• •3. Subject has history of prior bowel obstruction
• •4. Subject suffers UGI hemorrhage with hemodynamic shock requiring urgent endoscopy
• •5. Subject with any condition believed to have an increased risk for capsule retention such as Crohn's disease, intestinal tumors, radiation enteritis, incomplete colonoscopies due to obstructions or NSAID enteropathy
• •6. Subject has history of UGI tract surgery (e.g., Billroth I, Billroth II, esophagectomy, gastrectomy, bariatric procedure)
• •7. Pregnancy or nursing mothers
• •8. Subject has known allergy to conscious sedation medications
• •9. Presence of an electro-medical device (pacemaker or internal cardiac defibrillator)
• •10. Subject has altered mental status (e.g., hepatic encephalopathy) that would limit patient ability in swallowing the capsule
• •11. Known allergy to erythromycin
• •12. Subject is currently or within previous 30 days participating in another clinical study that may directly or indirectly affect the results of this study
• •13. Subject is not able to provide written informed consent.